Literature DB >> 27585217

Ebola virus disease and the eye.

Jessica G Shantha1, Steven Yeh, Quan Dong Nguyen.   

Abstract

PURPOSE OF REVIEW: The world has witnessed the largest Ebola virus disease (EVD) epidemic in West Africa with an unprecedented number of infected individuals and survivors. Many systemic and ocular complications have been reported in survivors. Herein, we review the ophthalmic complications associated with Ebolavirus. RECENT
FINDINGS: EVD causes ocular disease during acute infection and during convalescence. Acute patients manifest with conjunctivitis, subconjunctival hemorrhages, and acute vision loss of unclear cause. The most common complication during recovery is uveitis with live virus implicated in the pathogenesis in one case.
SUMMARY: This epidemic has brought to surface the spectrum of medical complications in EVD survivors with ophthalmic disease being one of the most critical because of its impact on individual functional status and its long-term economic implications. Future studies and programs are needed to appropriately evaluate the spectrum of ophthalmic disease in this at-risk population.

Entities:  

Mesh:

Year:  2016        PMID: 27585217     DOI: 10.1097/ICU.0000000000000313

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  5 in total

Review 1.  Negative regulators that mediate ocular immune privilege.

Authors:  Andrew W Taylor; Tat Fong Ng
Journal:  J Leukoc Biol       Date:  2018-02-12       Impact factor: 4.962

Review 2.  Post-exposure treatments for Ebola and Marburg virus infections.

Authors:  Robert W Cross; Chad E Mire; Heinz Feldmann; Thomas W Geisbert
Journal:  Nat Rev Drug Discov       Date:  2018-01-29       Impact factor: 84.694

Review 3.  Host Transcriptional Response to Ebola Virus Infection.

Authors:  Emily Speranza; John H Connor
Journal:  Vaccines (Basel)       Date:  2017-09-20

Review 4.  Ocular manifestations of recent viral pandemics: A literature review.

Authors:  Mohammad J J Taha; Mohammad T Abuawwad; Warda A Alrubasy; Shams Khalid Sameer; Taleb Alsafi; Yaqeen Al-Bustanji; Luai Abu-Ismail; Abdulqadir J Nashwan
Journal:  Front Med (Lausanne)       Date:  2022-09-23

Review 5.  Viruses go modular.

Authors:  Ariel Shepley-McTaggart; Hao Fan; Marius Sudol; Ronald N Harty
Journal:  J Biol Chem       Date:  2020-02-28       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.